Robert Dingwall kindly alerted me to Scott Kim, Peter Ubel, and Raymond De Vries, "
Pruning the Regulatory Tree,"
Nature 457 (29 January 2009), 534-535.
The authors have complex disciplinary backgrounds. Kim has an MD and a PhD in philosophy, and teaches psychiatry. De Vries has a PhD in sociology and the title of associate professor of bioethics/medical education. And Ubel has an MD and describes himself as a "physician and behavioral scientist." Together, they are unusually well prepared to think about the full range of disciplines affected by human subjects regulations.
The authors complain that IRB review of minimal risk research wastes time and money, infringes academic freedom, and threatens public health by impeding important research. They conclude that "it is unethical to support a system that creates a significant financial, scientific, clinical and ethical burden with virtually no counterbalancing good."
To fix this, they propose "a simple regulatory change that is far-reaching, equitable and yet low risk: exempt minimal-risk research from IRB review." In their scheme, researchers would still "complete a brief application describing research procedures, risks, burdens and the potential loss of otherwise expected benefits to the subjects. An institution-designated person reviews the application, and exempted protocols would not be subject to further IRB review. The application becomes the project's registration and serves as an accountability document."
This sounds fine on the surface, but the proposal raises some questions.